ADMA Biologics Inc (ADMA) financials · rev $510.2M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
ADMA Biologics Inc (ADMA) rev $510.2M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $510.2M | $426.5M |
| Cost of Revenue | $217.4M | $206.9M |
| Gross Profit | $292.8M | $219.6M |
| Operating Income | $191.4M | $139.0M |
| Net Income | $146.9M | $197.7M |
| EPS (Diluted) | $0.60 | $0.81 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $624.2M | $488.7M |
| Current Assets | $466.5M | $331.4M |
| Cash & Equivalents | $87.6M | $103.1M |
| Inventory | $206.5M | $170.2M |
| PP&E | $65.1M | $54.7M |
| Total Liabilities | $146.9M | $139.7M |
| Current Liabilities | $69.5M | $55.5M |
| Short-term Debt | $2.81M | N/A |
| Long-term Debt | $69.3M | $72.3M |
| Total Debt | $72.1M† | $72.3M† |
| Shareholders' Equity | $477.3M | $349.0M |
| Retained Earnings | -$161.7M | -$308.6M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $50.4M | $118.7M |
| CapEx | $22.6M | $8.23M |
| Investing Cash Flow | -$21.9M | -$8.57M |
| Financing Cash Flow | -$44.0M | -$58.3M |
| Net Change in Cash | -$15.5M | $51.8M |
| Free Cash Flow | $27.8M | $110.4M |
FAQ
What is ADMA P/E and revenue?
ADMA Biologics Inc (ADMA) rev $510.2M.
What is ADMA revenue?
ADMA Biologics Inc last cached revenue is $510.2M (FY2025).
Is ADMA profitable?
ADMA Biologics Inc last cached net income is $146.9M (FY2025).
What are ADMA total assets?
ADMA Biologics Inc last cached total assets are $624.2M (FY2025).
What is ADMA free cash flow?
ADMA Biologics Inc last cached free cash flow is $27.8M (FY2025).
Not investment advice. Cached statements, not a live tape.